Per Broberg
Overview
Explore the profile of Per Broberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
1871
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Strosberg J, Srirajaskanthan R, El-Haddad G, Wolin E, Chasen B, Kulke M, et al.
J Nucl Med
. 2021 Mar;
PMID: 33771903
We report the impact of Lu DOTATATE treatment on abdominal pain, diarrhea, and flushing, symptoms that patients with advanced midgut neuroendocrine tumors (NETs) often find burdensome. All patients enrolled in...
2.
Fritz I, Wagner P, Broberg P, Einefors R, Olsson H
Acta Oncol
. 2020 May;
59(9):1103-1109.
PMID: 32459128
Background: As tumors maintain an inflammatory microenvironment, anti-inflammatory medication can be useful in cancer therapy. We have previously shown an association with improved survival in melanoma for use of the...
3.
Ingvar A, Olsson H, Broberg P, Isaksson K, Ingvar C, Nielsen K
Acta Derm Venereol
. 2019 Oct;
100(1):adv00010.
PMID: 31663602
Prospective observational studies have shown previously that study participants have lower morbidity and mortality than non-participants. The aim of the current study was to determine whether participants in a prospective...
4.
Sundstrom J, Soderholm M, Soderberg S, Alfredsson L, Andersson M, Bellocco R, et al.
Int J Epidemiol
. 2019 Aug;
48(6):2018-2025.
PMID: 31363756
Background: Subarachnoid haemorrhage (SAH) is a devastating disease, with high mortality rate and substantial disability among survivors. Its causes are poorly understood. We aimed to investigate risk factors for SAH...
5.
Betancourt L, Pawlowski K, Eriksson J, Szasz A, Mitra S, Pla I, et al.
Sci Rep
. 2019 Mar;
9(1):5154.
PMID: 30914758
Metastatic melanoma is one of the most common deadly cancers, and robust biomarkers are still needed, e.g. to predict survival and treatment efficiency. Here, protein expression analysis of one hundred...
6.
Johnsson A, Broberg P, Kruger U, Johnsson A, Tornberg A, Olsson H
Eur J Cancer Care (Engl)
. 2019 Mar;
28(4):e13037.
PMID: 30895677
Introduction: Physical activity (PA) leads to improved survival in women following the diagnosis of breast cancer, but it is less clear whether PA has equally positive effects regardless of age...
7.
Escala-Garcia M, Guo Q, Dork T, Canisius S, Keeman R, Dennis J, et al.
Br J Cancer
. 2019 Feb;
120(6):647-657.
PMID: 30787463
Background: We examined the associations between germline variants and breast cancer mortality using a large meta-analysis of women of European ancestry. Methods: Meta-analyses included summary estimates based on Cox models...
8.
Borgquist S, Broberg P, Tojjar J, Olsson H
BMC Cancer
. 2019 Jan;
19(1):54.
PMID: 30634941
Background: A sizeable body of evidence suggests that statins can cease breast cancer progression and prevent breast cancer recurrence. The latest studies have, however, not been supportive of such clinically...
9.
Wu L, Shi W, Long J, Guo X, Michailidou K, Beesley J, et al.
Nat Genet
. 2018 Jun;
50(7):968-978.
PMID: 29915430
The breast cancer risk variants identified in genome-wide association studies explain only a small fraction of the familial relative risk, and the genes responsible for these associations remain largely unknown....
10.
Michailidou K, Lindstrom S, Dennis J, Beesley J, Hui S, Kar S, et al.
Nature
. 2017 Oct;
551(7678):92-94.
PMID: 29059683
Breast cancer risk is influenced by rare coding variants in susceptibility genes, such as BRCA1, and many common, mostly non-coding variants. However, much of the genetic contribution to breast cancer...